Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma

BACKGROUND: To overcome challenges with traditional response assessment in anti-angiogenic agents, the current study uses T1 subtraction maps to quantify volumetric radiographic response in monotherapy with cabozantinib, an orally bioavailable tyrosine kinase inhibitor with activity against vascular...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Neuro Oncol
Hoofdauteurs: Ellingson, Benjamin M, Aftab, Dana T, Schwab, Gisela M, Hessel, Colin, Harris, Robert J, Woodworth, Davis C, Leu, Kevin, Chakhoyan, Ararat, Raymond, Catalina, Drappatz, Jan, de Groot, John, Prados, Michael D, Reardon, David A, Schiff, David, Chamberlain, Marc, Mikkelsen, Tom, Desjardins, Annick, Holland, Jaymes, Ping, Jerry, Weitzman, Ron, Wen, Patrick Y, Cloughesy, Timothy F
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2018
Onderwerpen:
Neuroimaging
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6120362/
https://ncbi.nlm.nih.gov/pubmed/29660005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy054
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items